Therapeutics
- Finance
Halozyme Therapeutics, Inc. Q4 2025 Earnings Call Summary
Halozyme Therapeutics, Inc. recently reported its Q4 2025 earnings, showcasing a remarkable achievement of a record $1.4 billion in total…
Read More » -
Zcash (ZEC) Surges, Leap Therapeutics (LPTX) Jumps on Winklevoss-Backed Digital Asset Treasury
Former oncology biotech firm Leap Therapeutics (LPTX) made headlines earlier this month when they secured $58.9 million in funding from…
Read More » - Finance
Palantir, Sarepta Therapeutics, Denny’s, and More
Palantir Technologies, a leading AI software company, experienced a drop in its stock price despite posting record quarterly results that…
Read More » - Finance
Needham Lifts PT on Neumora Therapeutics (NMRA) to $8 From $6, Keeps a Buy Rating
Neumora Therapeutics, Inc. (NASDAQ:NMRA) has recently gained attention as one of the best stocks under $5 with the highest upside…
Read More » - Health
Biotech Startup Tahoe Therapeutics Raised $30 Million To Build AI Models Of Living Cells
Tahoe Therapeutics, a biotech startup co-founded by Kevin Shokat, Nima Alidoust, Johnny Yu, and Hani Goodarzi, is making significant strides…
Read More »